The current investigation quantitatively determined levels of CD56 and MICA expression in nonmalignant adult breast tissues with the hypothesis that lower levels of these markers would indicate suppressed NK cell immunoprotection in the breast epithelium and a higher incidence of cancer development. The gene discussed is NCAM1; the disease is cancer.